All articles starting with B
27,400 articles
BC-THAL study
BC-THAL study, formally Body Composition in Pediatric Patients With Thalassemia Major (NCT07204015), a ClinicalTrials.gov-registered study measuring fat mass and fat-free mass by bioelectrical impedance analysis in children with beta thalassemia major.
BC1
BC1 is a boccia sport class for athletes with severe neurological impairment of all four limbs (spastic quadriplegia, athetosis, or ataxia); BC1 athletes throw with a Sport Assistant and join BC2 athletes in the team event.
BC2 (classification)
BC2 is a boccia sport class for athletes with cerebral palsy or acquired brain damage, less severe than BC1, who throw with the hand and receive no assistant; also used in the BC1/BC2 team event.
BC200 lncRNA
BC200 (BCYRN1) is a 200-nucleotide primate brain cytoplasmic lncRNA on chromosome 2, transcribed by Pol III from an Alu element, that represses dendritic translation via eIF4A/eIF4B/PABP and is elevated in several cancers, notably breast cancer, as a blood biomarker.
BC3
BC3 is the most severely impaired boccia sport class (BC1-BC4): athletes cannot throw or kick the ball and use a ramp, pointer, and Ramp Operator; individual and pairs events under World Boccia rules.
BCAR1
BCAR1 (p130Cas, breast cancer anti-estrogen resistance 1) is a human scaffold protein gene at 16q23.1 encoding an 870-amino-acid CAS-family adaptor involved in adhesion, mechanosensing, embryonic heart development, and antiestrogen resistance and prognosis in breast and lung cancer.
BCAT1
BCAT1 (branched-chain amino acid transaminase 1, BCATc) is the cytosolic, brain-enriched PLP-dependent enzyme starting BCAA catabolism, overexpressed in glioma, NSCLC and pancreatic cancer and a drug-resistance target.
BCBL-1
BCBL-1 (Body Cavity Based Lymphoma-1) is a human primary effusion lymphoma cell line from a 40-year-old man, infected with KSHV/HHV-8 but not EBV, used widely for KSHV latency, reactivation, and PEL drug and xenograft studies.
BCBS 239
BCBS 239: the Basel Committee's January 2013 standard of 14 principles on effective risk data aggregation and risk reporting for systemically important banks, with a January 2016 G-SIB deadline that most banks have still not fully met.
BCC-CSM
BCC-CSM (Beijing Climate Center Climate System Model) is a fully coupled climate model developed by the Beijing Climate Center of the China Meteorological Administration, used for CMIP5 and CMIP6 and operational forecasting.
BCCT transporter family
The BCCT (betaine/choline/carnitine transporter) family is a bacterial secondary transporter family moving trimethylammonium substrates such as betaine, choline, and carnitine via Na+ or H+ symport or antiport, with BetP as the model osmoregulated member.
BCD (semiconductor process)
BCD is a semiconductor process technology that combines bipolar, CMOS, and DMOS transistors on a single chip, invented by SGS in 1985 and widely used for power management ICs.
BCE Inc.
BCE Inc., also known as Bell Canada Enterprises, is a Canadian communications holding company and parent of Bell Canada, created in 1983 with roots in Alexander Graham Bell's 1876 telephone patent.
BCG Freeze Dried Glutamate vaccine
BCG Freeze Dried Glutamate vaccine: WHO-prequalified (since 1987) lyophilized tuberculosis vaccine from Japan BCG Laboratory's Tokyo 172 strain, stabilized with sodium glutamate, intradermal, 2-8°C, 24-month shelf life.
BCG therapy
BCG therapy is an intravesical immunotherapy for non-muscle-invasive bladder cancer in which a live weakened Mycobacterium bovis strain is instilled into the bladder after tumor resection, preventing recurrence in most patients.
BCG vaccine
BCG (Bacille Calmette-Guérin) is the only licensed tuberculosis vaccine, a live attenuated M. bovis vaccine from 1921 that protects infants against severe TB but shows variable (0-80%) protection against adult pulmonary TB.
BCG Vaccine AJV
BCG Vaccine AJV is a WHO-prequalified (since 1994) freeze-dried tuberculosis vaccine from AJ Vaccines A/S, Copenhagen, using live attenuated M. bovis BCG Danish strain 1331, given intradermally as a two-vial set with Sauton diluent.
BCH code
A BCH code, or Bose-Chaudhuri-Hocquenghem code, is a cyclic error-correcting code over a finite field, described in 1959 and 1960 and widely used in communication systems and data storage.
BCI-Banco Credito
Banco de Crédito e Inversiones (Bci) is a Chilean universal bank founded in Santiago in 1937 by Juan Yarur Lolas and controlled by the Yarur family.
BCJR algorithm
The BCJR algorithm (Bahl–Cocke–Jelinek–Raviv) computes the probability of each bit in decoded data; it was published at IBM in 1974 and became the decoding engine of turbo codes.
Bcl-2
Bcl-2 (BCL2) is an anti-apoptotic protein of the BCL-2 family, discovered at the t(14;18) follicular lymphoma translocation; its inhibitor venetoclax is approved for CLL and AML, with MCL-1 upregulation the main resistance mechanism.
Bcl-2 family
Bcl-2 family, also BCL-2 protein family, a group of structurally related proteins with BH1-4 domains that regulate apoptosis at the mitochondria; includes anti-apoptotic BCL-2, BCL-XL, MCL-1, effectors BAX/BAK, BH3-only proteins, and drug targets of venetoclax.
BCL10
BCL10 (B-cell lymphoma/leukemia 10, aliases CARMEN, CIPER, CLAP) is a human gene at 1p22 encoding a 233-aa CARD-domain immune signaling adaptor. It forms the CARD11-BCL10-MALT1 (CBM) signalosome driving NF-κB in lymphocytes, forms helical filaments, and was discovered in 1999 as a MALT lymphoma translocation target; germline loss causes immunodeficiency 37.
BCL11A
BCL11A (EVI9, CTIP1), a zinc-finger transcriptional repressor gene on chromosome 2p16.1, silences fetal γ-globin genes and controls the fetal-to-adult hemoglobin switch; CRISPR editing of its erythroid enhancer underlies the approved therapy Casgevy.
BCL11B
BCL11B (CTIP2), a zinc-finger transcription factor gene at 14q32.2, governs T-cell commitment, neurodevelopment, and ILC2s; germline variants cause neurodevelopmental disorders and rearrangements mark T-ALL.
BCL2L11
BCL2L11, also called BIM, BAM, or BOD, is a human gene at 2q13 encoding a pro-apoptotic BH3-only BCL-2 family protein that activates BAX/BAK, inhibits autophagy via BECN1, and acts as a tumor suppressor.
BCL2L2
BCL2L2 (BCL-W, BCLW) is a human anti-apoptotic BCL-2 family gene on chromosome 14q11.2-q12 encoding a 193-aa survival protein; essential for mouse spermatogenesis, regulated by microRNAs, and lacking selective inhibitors.
BCL6
BCL6 (B-cell lymphoma 6, BCL6A) is a human zinc finger transcriptional repressor gene, master regulator of germinal center B cells and Tfh cells, and the most commonly involved oncogene in B-cell lymphomas such as DLBCL.
Bcp Asia
BCP Asia, or Blackstone Capital Partners Asia, is the series of Asia-focused private equity buyout funds of Blackstone, which closed its third fund at a reported $13.1 billion in 2026.
Bcp Infrastructure
BCP Infrastructure is the infrastructure private equity fund program of Bernhard Capital Partners, a Baton Rouge, Louisiana firm, whose two funds raised roughly $1 billion since 2020.